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Abstract  
Background: COPD is a disease due to oxidative stress causing low pulmonary function, resulting in 
low quality of life. A standard test to measure the quality of life in COPD is COPD Assessment Test 
(CAT). Vitamin C as antioxidant is widely available in the pulmonary epithelial fluid.  This study 
aimed to investigate the correlation between serum vitamin C level and CAT score in COPD. 
Methods: This cross-sectional study was conducted at Persahabatan Hospital, East Jakarta, 
involving 47 subjects using consecutive sampling method. Interview was used to assess subjects’ 
characteristics and vitamin C intake using semi-quantitative FFQ. Clinical classification, lung 
function, comorbidity, and CAT scores were gathered from medical records or interview. BMI was 
used to determine nutritional status, while vitamin C serum level was assessed using 
spectrophotometry. Results and conclusions: All subjects were male, mean age was 66.6 years, 
mostly ex-heavy  smokers, with decreased lung function, and 25% were undernourished. Vitamin C 
intake was sufficient, but low in serum vitamin C level and CAT score.There was no correlation 
between serum vitamin C level and CAT score.  
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Introduction 
Chronic obstructive pulmonary disease (COPD) is a 
chronic disease that causes high morbidity and 
mortality.1 This disease is the fourth leading cause 
of death worldwide and is projected to be the third 
leading cause of death in 2020.2,3 According to 
World Health Organization (WHO), in the top 10  
 
 
 
 
 
causes of death in the world in 2012, COPD was in 
the third rank with 6% deaths worldwide. In 
Indonesia, the prevalence is 5.6%, 2.7% in Jakarta, 
and the highest in East Jakarta as much as 3.8%.4,5 
Persahabatan Hospital data indicate that COPD 
patient visits increased from 616 in 2000 to 1735 in 
the year 2007.6 
Chronic obstructive pulmonary disease has an 
impact on the health status-related quality of life of 
sufferers. COPD ranks 12th as a cause of decreased 
quality of life (DALY, Disability Adjusted Life 
Years) in 1990 and is expected to rank 5th in 2020.7,8 
Patients with COPD have a cough, shortness of 
breath and tightness in the chest that would make the 
patients difficult to perform daily activities, giving 
an impact on the quality of life.9 Chronic 
Obstructive Pulmonary disease Assessment test 
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(CAT) is a standard test to measure the impact of 
disease on quality of life of COPD patients.10 
Pathogenesis of COPD is related to oxidative stress. 
Oxidative stress occurs when the formation of 
oxidants is not successfully offset by various 
antioxidants in the body. Oxidants come from 
outside the body such as cigarette smoke or air 
pollution and that comes from the inflammatory 
process. Oxidative stress will cause lipid 
peroxidation, which causes damage to the lungs due 
to decreased lung function.11,12 Systemic impact of 
these mechanisms would affect the quality of life of 
COPD patients.13,14 Various antioxidants are needed 
to counterbalance the oxidants. Vitamin C is a 
water-soluble antioxidant that is abundant in the 
lung epithelial lining fluid. Its ability as an electron 
donor, enabling vitamin C to scavenge and quench 
free radicals.11,15 
No previous studies had investigated the 
correlation between serum level of vitamin C and 
CAT score in COPD. However, some studies show 
correlation between serum vitamin C level and lung 
function and CAT scores with lung function.8,10,11 
The aim of this study was to investigate the 
correlation between serum vitamin C level and 
quality of life based on the scores of CAT of patients 
with COPD. 
 
Materials and methods 
 
This study was a cross-sectional study in 47 
outpatients with stable COPD at the Department of 
Asthma –COPD Persahabatan Hospital East Jakarta, 
from April to August 2016. Subjects were obtained 
using consecutive sampling method.  
Study subjects were those who met some 
inclusion criteria of stable COPD patients aged >18 
years, was diagnosed with COPD during the 
previous month, no diabetics, asthmatics, 
tuberculosis, lung cancer based on  medical records, 
nor vitamin C and multivitamin and minerals 
supplements. Of 138 subjects who visited, 59 people 
were excluded, 29 people refused to participate, two 
people were unable to complete the study procedure, 
and one blood sample was damaged.  
Data on subject’s characteristics, smoking 
history and vitamin C intake using a semi 
quantitative Food Frequency Questionnaire (FFQ) 
obtained from interviews. Data on clinical 
classification of COPD by the GOLD 2015, lung 
function by spirometry, CAT scores and history of 
cardiovascular diseases obtained from interviews 
and medical records. Anthropometry assessment 
was done using stadiometer for height and SECA 
scale 870 for weight measurement. Lung function 
test was performed using spirometry Microspiro HI 
28, Chest Corporation Japan, measuring forced 
expiratory volume in 1 second (FEV1%), forced vital 
capacity (FVC%) and the ratio FEV1 / FVC%. 
Vitamin C serum level was assessed 
spectrophotometrically using Multiskan Ascent. 
Two mL of non fasting venous serum was stored at 
-800C until analysis. 
Statistical analysis was performed using the 
Statistical Program for Social Science (SPSS) for 
Windows version 20. Data intake of vitamin C and 
CAT score with a median value (minimum-
maximum) and data serum level of vitamin C with a 
mean + standard deviations. Statistical analysis to 
see the difference in the proportion of two groups 
using Chi-square / Fisher's exact test and the mean 
difference between two groups with the Mann-
Whitney test. Spearman's rank test was used to see 
the correlation between serum vitamin C level and 
CAT score. Significancy level was p<0.05. This 
study has been approved by the Ethics Commission 
of Research and Health, Persahabatan Hospital, East 
Jakarta, Indonesia. 
 
Results 
 
Subjects were all males in this study. Figure. 1 
shows study subject’s characteristic: 66.6+ 8.0 years 
of age, mostly elderly. (Figure 1A), subjects’income 
was equally distributed in less or equal to Jakarta’s 
wage index (Figure 1B). Majority of subjects was 
former smokers (Figure 1C), while half of them was 
heavy smokers (Figure 1D). BMI of subjects in this 
study was 21.3+3.8 kg/m2, mostly had normal 
weight, with about 25% were underweight (Figure 
1E). 
Study subjects’ COPD clinical classification 
according to GOLD 2015 shown in Figure 2. Almost 
half of study subjects was  categorized as severe 
COPD (Figure 2 A). There was a decrease in lung 
function, as FEV1%, FVC% and FEV1/FVC% ratio 
was 49.6+20.7%, 66.8+18.6, and 50.7+10.4, 
respectively. Based on spirometry test, about half of 
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study subjects suffered from severe and very severe 
degree of lung function (Figure 2B). More study 
subjects were in the mild category of CAT score, 
with a median (minimum-maximum) value of 9 (1-
29). About half of study subjects suffered from 
cardiovascular comorbidity of ischemic heart 
disease, hypertension or congestive heart failure 
(Figure 2D). 
Vitamin C intake of study subjects was 124.2 
(18-480.1) mg/L, while  serum vitamin C level was 
21.1+4.1 µmol/L. There was no significant 
correlation (p=0.96) between vitamin C intake and 
serum level in this study. Almost double proportion 
of study subjects with sufficient vitamin C intake 
according to AKG Indonesia 2013 (Figure 3A). 
However, majority of subjects was in low vitamin C 
status based on serum vitamin C level (Figure 3B).  
A significant difference of vitamin C intake 
based on CAT score category: study subjects with 
mild CAT score category had higher vitamin C 
intake (p=0.008) as compared to those with severe 
CAT score. However, no significant difference of 
serum vitamin C level between the two CAT score 
categories, as shown in Table 1. 
Proportion of study subjects based on vitamin C 
intake and serum level based by CAT score category 
shown in Figure 4. There were more study subjects 
with low vitamin C intake (p=0.021) among severe 
CAT score category as compared to those with mild 
CAT category (Figure 4A). However, no difference 
of serum vitamin C level between mild and severe 
CAT score category (Figure 4B).   
Differences of vitamin C intake and serum level 
in groups with and without comorbidity shown in 
Table 2. Serum vitamin C level was lower (p=0.033) 
among those with comorbidity as compared to those 
without comorbidity. 
Proportion of study subjects’ vitamin C intake 
and serum level based on comorbidity shown in 
figure 5. No difference of study subjects’ proportion 
with low vitamin C intake with or without 
comorbidity (Figure 5A), however, more study 
subjects (p= 0.028) with low vitamin C level among 
those with comorbidity as compared to those 
without comorbidity (Figure 5B). 
There was no statistically significant correlation 
between serum vitamin C level and CAT score (p = 
0.949 and r = 0.01). 
 
Discussion 
 
The mean age of subjects in this study was 66.6 
years, mostly elderly.17 This result was consistent 
with a study by Draman et al8 in Malaysia with 
similar mean age of 66.4 years, but in contrast with 
a study by Cristovaoet al1 in Portuguese with a 
higher mean age of 71.3 years. Age is one risk factor 
on the development of COPD. The older a person, 
there will be a decrease in lung function, while more 
exposure to harmful substances.2,18 Fletcher and 
Peto’s study on 792 male workers aged 35-59 years 
observed for 8 years found that VEP1 declined 
throughout life, increasing with age.19 Kojima et al20 
showed data that COPD incidence among non-
smokers was lower at 25-49 years of age with a 
gradual increase at the age of 50-74 years, indicating  
a decline of lung function by age. 
All subjects in this study were male. The result 
of this study was similar to  Ghobadi et al10 that all 
subjects were male. Data of previous studies showed 
that patients with COPD were more among males 
than females, although lately the number is not much 
different, due to changes in smoking habits. This 
may be explained by the smoking prevalence of 16x 
higher in males (65.9%) as compared to women 
(4.2%).21 
Subjects’ income in this study was  consistent 
with Ismail et al6, despite different socio-economic 
parameters. Socio-economic is one risk factor of 
COPD.  
In this study, majority (87.2%) of study subjects 
was former smokers, consistent with Cristovao et al1 
who observed more former smoker patients with 
COPD than non-smokers, unlike Lin et al22, who 
found more non-smokers than former smokers. 
Major risk factor of COPD is smoking. Cigarette 
contains more free radicals and harmful substances 
which can increase oxidant load in the body.2,13 
Smoke as a risk factor for COPD is dose-dependent 
in nature: the longer and more number of cigarettes, 
the higher the risks for COPD.21 
The results of this study were consistent with 
Ismail et al6 who found that 84.6% of study subjects 
was moderate to heavy smokers. Kojima et al20 
showed that increasing incidence of COPD was 
higher in the group with higher Brinkman index. 
This supports the hypothesis that smoking is a risk 
factor for COPD. 
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The mean BMI of subjects in this study was 21.3 
kg/m2 considered as normal BMI, which more 
proportion of study subjects in this category. The 
results of this study was  consistent with Ismail et al6 
and  Lin et al22 studies with normal BMI of 22.13 
kg/m2 and 22.8 kg/m2, respectively. Unlikely, 
Cristovao et al1 observed a higher mean BMI of 
27.92 kg/m2, which was considered as overweight. 
The difference was  also seen in the study by Dhakal 
et al27 in which most of COPD subjects was with 
lower BMI of <18.5 kg/m2. 
BMI assessment was conducted to determine the 
nutritional status of patients with COPD in 
connection with the hypothesis that the IMT 
significantly affects the severity of disease.24 
Landbo et al24 states that underweight BMI is a risk 
factor that stands alone on COPD mortality and had 
stronger relationship with COPD severity. 
The CAT score in this study was 9, categorized 
as mild,  in contrast with two other studies with 
higher CAT score of 19.6 (Ghobadi et al10). The 
result was also different from Draman et al8 with 
CAT score of moderate category (11-20). This 
indicates that COPD probably provides minor health 
impact on more than half of study subjects. 
This study recorded 23 subjects (48.9%) 
suffered with comorbidity such as hypertension 
(14.9%), ischemic heart disease (17%), and 
congestive heart failure (17%). This study was in 
line with Negro et al25 who showed that 
cardiovasculer disease was important comorbidity 
among COPD patients. Cardiovascular diseases 
exist frequently amongst COPD, which would 
increase morbidity and mortality.21 Smoking is a risk 
factor for both cardiovascular disease and COPD 
due to increase oxidative stress and systemic 
inflammation.13 Therefore, the occurrence of 
comorbidity should be routinely monitored and 
treated in COPD patient.2 
Vitamin C intake in this study was sufficient 
with median of 124.2 mg/day, with a wide range of 
18-480.1 mg/day. This result was different from Lin 
et al22 and Ahmadi et al26 who showed lower vitamin 
C intake by COPD patients as compared to healthy 
individuals. This study found that 66% subjects was 
with sufficient vitamin C intake, in contrast to 
Pirabassi et al27 who showed low intake of vitamin 
C among 94% subjects with COPD in Malaysia. 
Low vitamin C intake may also occur due to low 
consumption of fruit and vegetables,27 as sources of 
vitamin C. Fruit is a good source of vitamin C 
because it is comsumed directly without undergoing 
cooking process, which may damage vitamin C 
content.28  
No correlation between vitamin C intake and 
serum level was observed in this study (p = 0.96). 
Many factors affect the amount of vitamin C in the 
diet such as processing, long storage as well as high 
temperature, which will reduce vitamin C content in 
the diet.28,29 Boiling vegetables reduces 50.9% of 
vitamin C content.29 
Vitamin C is absorbed as much as 80-90% in 
relation to is 30-180 mg of intake, but decreased 
absorption occurs as vitamin C consumption 
increases.30 Therefore, the recommendation of 
vitamin C daily consumption is  to consume several 
times each day with small portions.31 Mean intake of 
vitamin C in this study was 124.2 mg/day, within the 
range of intake for 80-90% absorption. Therefore, 
hindering  vitamin C absorption was unlikely to 
occur among our study subjects. The results of this 
study were different from a study by Dehghan et al32 
and Young et al33 who showed a correlation between 
vitamin C intake and serum level in healthy subjects. 
The correlation between the intake and levels of 
several nutrients, including vitamin C is influenced 
by age, sex, smoking, alcohol consumption, and 
comorbid.34,35 
Sufficient intake of vitamin C was more 
observed among subjects with mild CAT score than 
those with severe CAT score. There was  a 
significant negative correlation between vitamin C 
intake and CAT score in this study (p=0.002; r=-
0.43,).This result was consistent with Grievink et 
al36 in healthy subjects as vitamin C was 
significantly associated with symptoms of cough 
(odds ratio 0.66, 95% CI: 0.50-0.87), and Menaas et 
al37 also showed an association between vitamin C 
intake and cough symptoms among healthy 
smokers. The ability of vitamin C to protect 
respiratory symptoms such as cough, may explain 
these findings. 
Sufficient intake of vitamin C was observed 
among subjects without comorbidity as compared to 
those with comorbidity. Congestive heart failure as 
observed in this study shows symptoms  of reduced 
appetite, fatigue, and shortness of breath. These 
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symptoms might cause less sufficient intake of 
vitamin C in the group with comorbidity. 
Furthermore, intake of antioxidants such as vitamins 
C and E has an effect of protecting against 
cardiovascular disease through stress oxidative 
reduction.38 
The mean serum vitamin C level of 
21.1+4.1mol/L in this study was considered low, 
observed among 72.3% of study subjects. The result 
was consistent with Lin et al22, Cristovao et al1 and 
Chittimoju et al15 who found that serum vitamin C 
level was significantly lower in patients with COPD 
compared to healthy people. Low serum vitamin C 
level in this study might be due to vitamin C usage 
to cope with oxidative stress among COPD patients, 
through two mechanisms, namely reduction of free 
radicals, and it is needed for the regeneration of 
vitamin E, which in turn serves to function in 
oxidative stress.11,12  
The proportion of study subjects with low serum 
vitamin C level was observed a lot more in the group 
with comorbidity than without comorbidity. This 
result was  consistent with Padayatti et al39 stated 
that low level of vitamin C was associated with 
hypertension and impaired endothelial function, 
because vitamin C improves endothelial 
dysfunction, and protects  against heart and blood 
vessel system. The significantly lower serum 
vitamin C level in the group with comorbidity 
indicates that comorbid is one of the factors that 
affect levels of vitamin C serum. 
Several studies illustrated a possible relation 
between serum vitamin C level and CAT score. 
However, the correlation between serum vitamin C 
level and CAT score of COPD patients was not 
significant (p=0.949 ; r=0.01) in our study. This 
maybe due to many factors that affect the quality of 
life in COPD in addition to symptoms such as 
shortness of breath, cough, sputum production and 
limited physical activity. Other factors that can 
affect the quality of life is age, sex and nutritional 
status based on BMI, smoking, economic status, 
degree of disease severity based on pulmonary 
function, the occurence of comorbidity, depression 
and anxiety, as well as other factors such as 
exacerbations, hospitalizations, number of used 
drugs, duration of illness and low education.23 
Different proportions of study subjects with serum 
vitamin C level in the CAT score category was not 
statistically significant, indicating that low serum 
vitamin C level was not associated with increased 
severity of CAT score. 
Pawar et al11,12 stated that there was a significant 
positive correlation between levels of vitamin C 
serum and lung function. Ghobadi et al10 stated that 
there was a correlation between the scores of CAT 
with FEV1% and FVC%. These results were 
corroborated by Draman et al8 who showed that 
there were significant differences of CAT score on 
every degree of lung function. Salma et al40 showed 
data on CAT score which was positively correlated 
with the severity of lung function based on FEV1%. 
Therefore, lung function is one of the factors that 
influence the quality of life in COPD,23,24 and lung 
function was positively significant correlated with 
higher levels of  serum vitamin C.11,12  
This study showed a significant negative 
correlation (p = 0.001, r = -0.48) between CAT score 
and FEV1%, but no significant correlation between 
serum vitamin C level and FEV1% (p = 0.59). 
FEV1% indicates level of air obstruction in the 
respiratory system: the higher the FEV1% - the lesser 
the air obstruction which means less burden of 
respiration experienced by the COPD patients. A 
burden during respiration influences quality of life 
as indicated by lower CAT score. Serum vitamin C 
level is not directly correlated with the level of air 
obstruction, as the effect of vitamin C in COPD 
patients as antioxidant is to reduce the destruction 
effect of oxidants on respiratory organ system. This 
may explain why unlike FEV1%, there was no 
correlation between serum vitamin C level and CAT 
score in this study as FEV1% has a more direct 
influence on CAT score as compared to vitamin C. 
In conclusion, no correlation was observed 
between serum vitamin C level and CAT score in 
this study. Further study is needed to confirm this 
finding by assessing oxidative stress as well as anti 
oxidants among COPD patients of each clinical 
diagnosis. 
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 Figure 1. Distribution of Study Subjects by Age, Income, Smoking History, and Nutritional 
Status Based on BMI  
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Figure 4. Proportion of Study Subjects in Case of Intake and Serum  Vitamin C Level by CAT Score 
 
 
 
Figure 5. Proportion of Study Subjects in Case of Intake and Serum  Vitamin C Level In Comorbid 
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